Prostatic cancer with metastasis to the testis -A case report Metastatic carcinoma to the testis is very rare. The incidence of secondary testicular tumors ranges from 0.02 to 2.5% among autopsies in general. Despite the high incidence of prostatic adenocarcinoma and its ability for wide dissemination, metastatic cancer to the testis is a rare phenomenon of prostate carcinoma with only 80 cases reported in the literature. It is diagnosed in autopsies or incidentally, following therapeutic orchiectomies in more advanced stages of the disease.
INTRODUCTION
Prostate adenocarcinoma is the most frequently diagnosed neoplasm in men and its natural history is largely known. The most common metastatic sites are iliac lymph nodes, bones and lungs, then followed more rarely by bladder, liver, adrenal and brain. 1 Metastatic carcinoma to the testis, excluding lymphomas and leukemias, is an extremely rare phenomenon. 2 The majority of these cases are presented at autopsy in about 2.5% of men with malignant tumors or are incidentally detected during therapeutic orchiectomy for prostatic cancer. 3 Of the metastatic lesions found, most are from prostate and lung cancer, and usually resemble 
CASE REPORT
A 70-year-old gentleman presented to the department of urology at our hospital with complaints of urinary obstruction and irritation. Digital rectal examination showed an asymmetric prostate with indurated and fixed left lobe. Trucut biopsy was performed and prostatic acinar adenocarcinoma was detected (Gleason score 4+3=7). Prostate-specific antigen (PSA) level was 67.5ng/ ml at initial study that increased to 142.5ng/ml on serial observation. Abdominopelvic CT scan was carried out and 
DISCUSSION
Metastatic testicular tumors are unusual, with a total of 265 reported cases found in the literature. 4 Pugh reported that 0.9% of 2739 testis tumors were metastatic. 5 The most common primary sites of metastases to testis are prostate, lung, skin (malignant melanoma), colon and kidney in order of decreasing frequency, collectively comprising 72% of all reported cases. 4 In Mayo Clinic experience, of the 550 patients with testicular tumors, 20 had a tumor metastatic to the testis and the site of the primary tumor was the prostate in 12 patients (60% of the metastatic tumors). 6 Most of the patients with metastatic tumors tend to be in the sixth or seventh decade of life, older than the patients with primary germ cell neoplasm. Metastasis was bilateral in a small proportion of cases. 7 The majority of reported cases are detected either as incidental findings in surgical specimens following therapeutic orchiectomy or upon excision of hydrocele sacs or at autopsy. Only 20% of the reported cases are clinically apparent testicular metastases. 4 Prostatic cancer usually spreads to the testis via lymphatic or venous routes or through direct extension via vas deferens, and seldom invades the interstitium through the seminiferous tubules. 8 We did not find any lesions in the epididymis and rete testis in this patient. Hence we ruled out a direct extension of the tumor via vas deferens in our case. The tumor cells were more likely spread by the lymphatic or venous route but we could not determine which. The metastatic lesion in our patient was unilateral and detected incidentally. It was impossible to identify the metastatic lesion in a physical examination or in macroscopic dissection of the testis. The malignant epithelial cells were arranged in glandular form, suggesting that this was a metastatic lesion from an adenocarcinoma. The presence of a history of prostatic adenocarcinoma helped us to recognize this as a metastatic prostatic adenocarcinoma. Positive immunohistochemical stain for PSA confirmed this diagnosis.
Interestingly, the differentiation of cells in the metastatic lesion was similar to the primary tumor (Gleason score 4+3=7). In conclusion, all testes removed for early or delayed hormonal therapy of prostate cancer should be sent for routine histologic examination. Whole testicular tissue should be prepared and examined microscopically because macroscopic dissection of the testis may not show the metastatic lesion. Some patients whose disease is not clinically metastatic, and for whom radical surgery is not suitable because of their age or poor performance status, may be treated with early hormone ablation therapy (orchiectomy + antiandrogen therapy). In such patients any incidental testicular metastasis provides the real 
